INMODE LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18.49 USD | +2.15% |
|
-0.86% | -16.86% |
| May. 03 | UBS Adjusts Price Target on InMode to $20 From $26, Maintains Neutral Rating | MT |
| May. 02 | InMode Shares Rise; Q1 Non-GAAP Earnings, Revenue Fall; 2024 Guidance Cut | MT |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
Financials (USD)
| Sales 2024 * | 480M | Sales 2025 * | 520M | Capitalization | 1.56B |
|---|---|---|---|---|---|
| Net income 2024 * | 165M | Net income 2025 * | 189M | EV / Sales 2024 * | 1.24 x |
| Net cash position 2024 * | 968M | Net cash position 2025 * | 1.19B | EV / Sales 2025 * | 0.72 x |
| P/E ratio 2024 * |
9.56
x | P/E ratio 2025 * |
8.45
x | Employees | 581 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.31% |
More Fundamentals
* Assessed data
More news
Latest transcript on InMode Ltd.
More recommendations
More press releases
| 1 day | +2.15% | ||
| 1 week | -0.86% | ||
| Current month | +7.56% | ||
| 1 month | +3.18% | ||
| 3 months | -21.88% | ||
| 6 months | -6.71% | ||
| Current year | -16.86% |
1 week
18.09
18.70
1 month
16.7218.95
Current year
16.7226.80
1 year
16.7248.25
3 years
16.7299.27
5 years
6.5399.27
10 years
6.5399.27
| Managers | Title | Age | Since |
|---|---|---|---|
Michael Kreindel
FOU | Founder | 57 | 08-01-01 |
Moshe Mizrahy
CEO | Chief Executive Officer | 71 | 08-01-01 |
Yair Malca
DFI | Director of Finance/CFO | 46 | 16-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Bruce Mann
BRD | Director/Board Member | 89 | 19-08-06 |
Moshe Mizrahy
CEO | Chief Executive Officer | 71 | 08-01-01 |
Michael Kreindel
FOU | Founder | 57 | 08-01-01 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.54% | 5 M€ | -1.80% | - | |
| 0.10% | 12 M€ | -.--% | - | |
| 0.10% | 17 M€ | +6.39% | - | |
| 0.05% | 746 M€ | -.--% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-13 | 18.49 | +2.15% | 937,849 |
| 24-05-10 | 18.1 | -1.42% | 1,001,694 |
| 24-05-09 | 18.36 | +0.33% | 1,150,469 |
| 24-05-08 | 18.3 | -1.08% | 1,185,723 |
| 24-05-07 | 18.5 | -0.80% | 1,185,601 |
Delayed Quote Nasdaq, May 13, 2024 at 04:00 pm EDT
More quotes
Inmode Ltd is an Israel-based global provider of energy-based, minimally-invasive surgical medical treatment solutions. Company's products and solutions are primarily designed to address three energy-based treatment categories comprised of: face and body contouring; medical aesthetics; and womenâs health. The Company have developed and commercialized products utilizing medically-accepted RF energy technology, which can penetrate deep into the subdermal fat, allowing adipose tissue remodeling. It's RF energy-based proprietary technologies - Radio Frequency Assisted Lipolysis (RFAL), Deep Subdermal Fractional RF, Simultaneous Fat Destruction and Skin Tightening and Deep Heating Collagen Remodeling for skin and human natural openings- represent a paradigm shift in the minimally-invasive aesthetic solutions market. These technologies are used by physicians to remodel subdermal adipose, or fatty tissue in a variety of procedures.
Calendar
2024-05-20
- Barclays West Coast Bus Trip
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
18.49
USD
Average target price
25.6
USD
Spread / Average Target
+38.45%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -16.86% | 1.53B | |
| +11.29% | 226B | |
| +8.76% | 188B | |
| +12.90% | 137B | |
| +25.95% | 108B | |
| +0.34% | 63.19B | |
| +11.08% | 52.26B | |
| +5.62% | 51B | |
| +6.28% | 43.89B | |
| +4.80% | 38.07B |
- Stock Market
- Equities
- INMD Stock